Log In
Print
BCIQ
Print
Print this Print this
 

Oral glucocerebrosidase (GCD) (PRX-112)

  Manage Alerts
Collapse Summary General Information
Company Protalix BioTherapeutics Inc.
DescriptionOral encapsulated plant cell-expressed recombinant form of human Glucocerebrosidase (GBA; GCase)
Molecular Target Glucocerebrosidase (GBA) (GCase)
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPhase II
Standard IndicationGaucher's disease
Indication DetailsTreat Gaucher's disease; Treat Gaucher's disease in treatment-naïve patients
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today